Biotin Anti-Human CD10 Antibody[CB-CALLA]

Biotin Anti-Human CD10 Antibody[CB-CALLA]

The Biotin Anti-Human CD10 Antibody[CB-CALLA] is a highly specific and reliable tool for the detection and analysis of CD10 expression in human samples. CD10, also known as CALLA, is a cell surface enzyme that plays a crucial role in the development and differentiation of various cell types, including lymphocytes, granulocytes, and bone marrow precursor cells. This antibody is conjugated with biotin, allowing for easy and efficient detection using streptavidin-based detection systems.

This antibody is produced using advanced recombinant DNA technology, ensuring high purity and batch-to-batch consistency. It has been extensively validated for use in various applications, including flow cytometry, immunohistochemistry, and immunofluorescence. The Biotin Anti-Human CD10 Antibody[CB-CALLA] exhibits exceptional sensitivity and specificity, enabling accurate identification and quantification of CD10-positive cells in complex biological samples.

With its excellent performance characteristics, this antibody is an invaluable tool for researchers and clinicians studying hematopoiesis, lymphocyte development, and various hematological malignancies. It enables the identification of CD10 expression patterns in different cell populations, aiding in the diagnosis, prognosis, and monitoring of diseases such as acute lymphoblastic leukemia, Burkitt lymphoma, and chronic lymphocytic leukemia. The biotin conjugation provides versatility, allowing for multiple detection options and compatibility with a wide range of experimental setups.

In summary, the Biotin Anti-Human CD10 Antibody[CB-CALLA] is a highly specific, reliable, and versatile tool for the detection and analysis of CD10 expression. Its exceptional performance characteristics make it an essential reagent for researchers and clinicians working in the fields of hematology, immunology, and oncology.